Nasdaq moves to delist GlucoTrack over minimum bid price violation
Bitget2026/10/29 21:25- Nasdaq notified GlucoTrack on October 28, 2026, that its securities would be delisted for failing to meet minimum bid price requirements.
- Trading in its common stock on Nasdaq will be suspended at the open on October 30, 2026.
- The closing bid price of $0.87 on October 14, 2026, breached the exception granted under Nasdaq Listing Rule 5550(a)(2).
- The exception required a closing bid price of at least $1 each trading day through November 9, 2026.
- The company expects its common stock to be quoted on OTC Markets upon suspension, with an application planned for the OTCID Market.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley: AI capital expenditure may reach 10 to 15 trillions USD in the next 10 years
Morgan Stanley stated that capital expenditure in the artificial intelligence (AI) sector could reach $10-15 trillions over the next decade.
Morgan Stanley: Apple's target price lowered to $350
Autoliv completes acquisition of MCF Safety Belts
Refining profits surge and oil prices soar; Saudi Aramco Q3 profits grow by 9% and maintains a dividend of 21.9 billions USD.
Driven by rising refining profits and oil prices, Saudi Aramco's third-quarter profits increased by 9%.
Crypto prices
More
